MapLight Therapeutics MPLT
NASDAQ MPLT
$10.12 -0.03 (-0.30%)
As of: Sep 30, 2026 · 10:25 AM EDT

MapLight Therapeutics (MPLT) Operating Expenses (2024 - 2026)

Updated

MapLight Therapeutics (MPLT) reported Operating Expenses of $63.55 million for Q2 2026, up 107.2% from $30.66 million a year earlier.

Analysis

MapLight Therapeutics (MPLT) Operating Expenses (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, MapLight Therapeutics' Operating Expenses came in at $209.09 million; for FY2025, it came in at $169.08 million, up 103.8% from FY2024.

  • By year, Operating Expenses came in at $82.95 million in FY2024.
  • Five-year quarterly Operating Expenses spans a low of $20.89 million in Q3 2024 and a high of $83.38 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 MapLight Therapeutics 474.82 Mn 474.82 Mn - 63.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63.55 Mn
Dec 31, 2025 83.38 Mn
Sep 30, 2025 31.50 Mn
Jun 30, 2025 30.66 Mn
Dec 31, 2024 22.78 Mn
Sep 30, 2024 20.89 Mn
API Access

MapLight Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=MPLT&period=max&api_key=YOUR_API_KEY